Literature DB >> 11027848

Both corticotropin releasing factor and neuropeptide Y are involved in the effect of orexin (hypocretin) on the food intake in rats.

T Ida1, K Nakahara, T Kuroiwa, K Fukui, M Nakazato, T Murakami, N Murakami.   

Abstract

Orexin (hypocretin) is a peptide that has been found to stimulate food intake in rats. However, we have recently demonstrated that orexin stimulates the release of corticotropin releasing hormone (CRF) which has been known to decrease the food intake. Therefore, we examined the mechanism of effect of orexin on food intake. Although the other appetite stimulating peptides; neuropeptide Y (NPY), agouti-related peptide (AGRP) and one of the growth hormone releasing secretagogue (GHRP-6) stimulated dose-dependently the food intake during 2 h in the early light period, orexin did not increase significantly the food intake. No significant increase was also observed during 2 h in the early dark period. However, pretreatment with alpha-helical CRF, an antagonist of CRF, or anti-CRF antiserum resulted in significant increase of food intake by orexin. Orexin-stimulated feeding under these conditions was blocked by NPY Y1 receptor antagonist (1229U91). In an 8 h-fasting rat, anti-orexin serum decreased slightly the food intake. These results suggest that effect of orexin on the food intake may be complex because of orexin-CRF and orexin-NPY linkage.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11027848     DOI: 10.1016/s0304-3940(00)01498-1

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  12 in total

Review 1.  Addiction and arousal: the hypocretin connection.

Authors:  Benjamin Boutrel; Luis de Lecea
Journal:  Physiol Behav       Date:  2007-11-22

2.  Activation of orexin/hypocretin neurons is associated with individual differences in cued fear extinction.

Authors:  Amanda C Sharko; Jim R Fadel; Kris F Kaigler; Marlene A Wilson
Journal:  Physiol Behav       Date:  2016-10-13

Review 3.  Neuropeptides controlling energy balance: orexins and neuromedins.

Authors:  Joshua P Nixon; Catherine M Kotz; Colleen M Novak; Charles J Billington; Jennifer A Teske
Journal:  Handb Exp Pharmacol       Date:  2012

4.  Orexin a stimulates hypothalamic-pituitary-adrenal (HPA) axis function, but not food intake, in the absence of full hypothalamic NPY-ergic activity.

Authors:  Griselda Moreno; Mario Perelló; Rolf C Gaillard; Eduardo Spinedi
Journal:  Endocrine       Date:  2005-03       Impact factor: 3.633

Review 5.  Stress and arousal: the corticotrophin-releasing factor/hypocretin circuitry.

Authors:  Raphaëlle Winsky-Sommerer; Benjamin Boutrel; Luis de Lecea
Journal:  Mol Neurobiol       Date:  2005-12       Impact factor: 5.590

6.  Centrally administered orexin A increases motivation for sweet pellets in rats.

Authors:  A J Thorpe; J P Cleary; A S Levine; C M Kotz
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

Review 7.  Role of orexin/hypocretin in dependence and addiction.

Authors:  Ruth Sharf; Maysa Sarhan; Ralph J Dileone
Journal:  Brain Res       Date:  2009-08-20       Impact factor: 3.252

8.  Neuropeptide Y inhibits hypocretin/orexin neurons by multiple presynaptic and postsynaptic mechanisms: tonic depression of the hypothalamic arousal system.

Authors:  Li-Ying Fu; Claudio Acuna-Goycolea; Anthony N van den Pol
Journal:  J Neurosci       Date:  2004-10-06       Impact factor: 6.167

Review 9.  The hypocretin/orexin system.

Authors:  I O Ebrahim; R S Howard; M D Kopelman; M K Sharief; A J Williams
Journal:  J R Soc Med       Date:  2002-05       Impact factor: 18.000

10.  The in vitro regulation of growth hormone secretion by orexins.

Authors:  Chen Chen; Ruwei Xu
Journal:  Endocrine       Date:  2003-10       Impact factor: 3.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.